Tumor Necrosis Factor Alpha Mediates Lethal Activity of Killed Gram-negative and Gram-positive Bacteria in D-galactosamine-treated Mice

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1991 Jun 1

PMID 2037372

Citations 68

Authors

M A Freudenberg

C Galanos

Affiliations

Soon will be listed here.

Abstract

Treatment with D-galactosamine increases sensitivity of lipopolysaccharide (LPS)-responder mice to the lethal effects of LPS, while nonresponder mice remain resistant (M.A. Freudenberg, D. Keppler, and C. Galanos, Infect. Immun. 51:891-895, 1986). In the present study it is shown that, in contrast to LPS, killed gram-negative bacteria (Salmonella abortus equi and S. typhimurium) were highly toxic for D-galactosamine-treated LPS-responder (C57BL/10 ScSN and C3H/HeN) and -nonresponder (C57BL/10 ScCR and C3H/HeJ) mice, although to a higher extent in the former strains. Also, killed gram-positive bacteria (Staphylococcus aureus, Propionibacterium acnes, and Mycobacterium phlei) exhibited toxicity for D-galactosamine-treated mice, LPS-responder and -nonresponder mice being equally susceptible. Evidently, bacterial components other than LPS may exhibit lethal effects in sensitized animals. In all cases, the lethality of LPS and of bacteria was inhibited by anti-tumor necrosis factor alpha (TNF-alpha) serum. While LPS induced TNF-alpha in vitro only in macrophages from LPS-responder mice, gram-negative and gram-positive bacteria induced TNF-alpha also in macrophages from LPS-nonresponder mice. The data show that TNF-alpha is a common endogenous mediator of the lethal activity of gram-negative and gram-positive bacteria.

Citing Articles

Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.

Schulte R, Wohlleber D, Unrau L, Geers B, Metzger C, Erhardt A Int J Mol Sci. 2020; 21(7).

PMID: 32260486 PMC: 7177299. DOI: 10.3390/ijms21072523.

Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.

Mouhsine H, Guillemain H, Moreau G, Fourati N, Zerrouki C, Baron B Sci Rep. 2017; 7(1):3424.

PMID: 28611375 PMC: 5469758. DOI: 10.1038/s41598-017-03427-z.

Quantitative Determination of Stilbenoids and Dihydroisocoumarins in Shorea roxburghii and Evaluation of Their Hepatoprotective Activity.

Ninomiya K, Chaipech S, Kunikata Y, Yagi R, Pongpiriyadacha Y, Muraoka O Int J Mol Sci. 2017; 18(2).

PMID: 28230758 PMC: 5343985. DOI: 10.3390/ijms18020451.

Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia - like pathology in Swiss albino mice.

Lakshmikanth C, Jacob S, Kudva A, Latchoumycandane C, Yashaswini P, Sumanth M Sci Rep. 2016; 6:34666.

PMID: 27698491 PMC: 5048175. DOI: 10.1038/srep34666.

Hepatoprotective Limonoids from Andiroba (Carapa guianensis).

Ninomiya K, Miyazawa S, Ozeki K, Matsuo N, Muraoka O, Kikuchi T Int J Mol Sci. 2016; 17(4).

PMID: 27104518 PMC: 4849045. DOI: 10.3390/ijms17040591.

References

Selye H, Tuchweber B, Bertok L . Effect of lead acetate on the susceptibility of rats to bacterial endotoxins. J Bacteriol. 1966; 91(2):884-90. PMC: 314942. DOI: 10.1128/jb.91.2.884-890.1966. View

Matsuura M, Galanos C . Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. Infect Immun. 1990; 58(4):935-7. PMC: 258563. DOI: 10.1128/iai.58.4.935-937.1990. View

Melchers F, Braun V, Galanos C . The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975; 142(2):473-82. PMC: 2189908. DOI: 10.1084/jem.142.2.473. View

Galanos C, LUDERITZ O, Westphal O . Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A. 1979; 243(2-3):226-44. View

Galanos C, Freudenberg M, REUTTER W . Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A. 1979; 76(11):5939-43. PMC: 411768. DOI: 10.1073/pnas.76.11.5939. View

Tanamoto K, Zahringer U, McKenzie G, Galanos C, Rietschel E, LUDERITZ O . Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun. 1984; 44(2):421-6. PMC: 263535. DOI: 10.1128/iai.44.2.421-426.1984. View

Agarwal M, Lazar G . Biological reactions to bacterial endotoxins in the non-responder C3H/HeJ mouse strain. Microbios. 1984; 39(157-158):193-207. View

Schramek S, Kazar J, Sekeyova Z, Freudenberg M, Galanos C . Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect Immun. 1984; 45(3):713-7. PMC: 263355. DOI: 10.1128/iai.45.3.713-717.1984. View

Aggarwal B, Kohr W, Hass P, Moffat B, Spencer S, Henzel W . Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985; 260(4):2345-54. View

10.

Beutler B, Milsark I, Cerami A . Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985; 229(4716):869-71. DOI: 10.1126/science.3895437. View

11.

Old L . Tumor necrosis factor (TNF). Science. 1985; 230(4726):630-2. DOI: 10.1126/science.2413547. View

12.

Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y . Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation. Immunol Lett. 1985; 11(2):83-8. DOI: 10.1016/0165-2478(85)90147-6. View

13.

Freudenberg M, Keppler D, Galanos C . Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun. 1986; 51(3):891-5. PMC: 260982. DOI: 10.1128/iai.51.3.891-895.1986. View

14.

Izumi S, Hirai O, Hayashi K, Konishi Y, OKUHARA M, Kohsaka M . Induction of a tumor necrosis factor-like activity by Nocardia rubra cell wall skeleton. Cancer Res. 1987; 47(7):1785-92. View

15.

Lehmann V, Freudenberg M, Galanos C . Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987; 165(3):657-63. PMC: 2188282. DOI: 10.1084/jem.165.3.657. View

16.

Bartholeyns J, Freudenberg M, Galanos C . Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun. 1987; 55(9):2230-3. PMC: 260683. DOI: 10.1128/iai.55.9.2230-2233.1987. View

17.

Fast D, Schlievert P, Nelson R . Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol. 1988; 140(3):949-53. View

18.

Jupin C, Anderson S, Damais C, ALOUF J, Parant M . Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med. 1988; 167(3):752-61. PMC: 2188868. DOI: 10.1084/jem.167.3.752. View

19.

Freudenberg M, Galanos C . Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun. 1988; 56(5):1352-7. PMC: 259829. DOI: 10.1128/iai.56.5.1352-1357.1988. View

20.

Beutler B, Cerami A . Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988; 57:505-18. DOI: 10.1146/annurev.bi.57.070188.002445. View